211 related articles for article (PubMed ID: 28186997)
1. Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma.
Ying X; Han SX; He CC; Zhou CY; Dong YP; Cai MJ; Sui X; Ma CX; Sun X; Zhang YY; Gou WL; Mason C; Zhu Q
Oncotarget; 2017 Apr; 8(15):24828-24839. PubMed ID: 28186997
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma.
Shao Q; Ren P; Li Y; Peng B; Dai L; Lei N; Yao W; Zhao G; Li L; Zhang J
Int J Oncol; 2012 Sep; 41(3):1061-7. PubMed ID: 22692946
[TBL] [Abstract][Full Text] [Related]
3. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
[TBL] [Abstract][Full Text] [Related]
4. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.
Liu M; Zheng SJ; Chen Y; Li N; Ren PF; Dai LP; Duan ZP; Zhang JY
J Immunol Res; 2014; 2014():906532. PubMed ID: 24955377
[TBL] [Abstract][Full Text] [Related]
6. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY
Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685
[TBL] [Abstract][Full Text] [Related]
7. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
[TBL] [Abstract][Full Text] [Related]
8. An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma.
Hong Y; Long J; Li H; Chen S; Liu Q; Zhang B; He X; Wang Y; Li H; Li Y; Zhang T; Lu C; Yan H; Zhang M; Li Q; Cao B; Bai Z; Wang J; Zhang Z; Zhu S; Zheng J; Ou X; Ma H; Jia J; You H; Wang S; Huang J
EBioMedicine; 2015 May; 2(5):438-46. PubMed ID: 26137588
[TBL] [Abstract][Full Text] [Related]
9. A cancer-related protein 14-3-3ΞΆ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.
Liu M; Liu X; Ren P; Li J; Chai Y; Zheng SJ; Chen Y; Duan ZP; Li N; Zhang JY
Tumour Biol; 2014 May; 35(5):4247-56. PubMed ID: 24390614
[TBL] [Abstract][Full Text] [Related]
10. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
[TBL] [Abstract][Full Text] [Related]
11. Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens.
Koziol JA; Imai H; Dai L; Zhang JY; Tan EM
Cancer Immunol Immunother; 2018 May; 67(5):835-841. PubMed ID: 29497780
[TBL] [Abstract][Full Text] [Related]
12. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study.
Okada R; Otsuka Y; Wakabayashi T; Shinoda M; Aoki T; Murakami M; Arizumi S; Yamamoto M; Aramaki O; Takayama T; Wakiyama S; Yanaga K; Amikura K; Kaneko H; Shimada H
Int J Cancer; 2020 Nov; 147(9):2578-2586. PubMed ID: 32574375
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.
Ma Y; Qiu C; Wang B; Zhang X; Wang X; Aguilera RJ; Zhang JY
Cells; 2022 Oct; 11(20):. PubMed ID: 36291095
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.
Zhou JW; Li Y; Yue LX; Luo CL; Chen Y; Zhang JY
Tumour Biol; 2016 Feb; 37(2):2547-53. PubMed ID: 26386724
[TBL] [Abstract][Full Text] [Related]
15. Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma.
Looi KS; Nakayasu ES; Diaz RA; Tan EM; Almeida IC; Zhang JY
J Proteome Res; 2008 Sep; 7(9):4004-12. PubMed ID: 18672925
[TBL] [Abstract][Full Text] [Related]
16. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
Wang J; Xu Y; Zhao H; Zhang X
J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
[TBL] [Abstract][Full Text] [Related]
17. Identification of serologic biomarkers for predicting microvascular invasion in hepatocellular carcinoma.
Yu YQ; Wang L; Jin Y; Zhou JL; Geng YH; Jin X; Zhang XX; Yang JJ; Qian CM; Zhou DE; Liu DR; Peng SY; Luo Y; Zheng L; Li JT
Oncotarget; 2016 Mar; 7(13):16362-71. PubMed ID: 26918350
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma.
Wang K; Chen Y; Liu S; Qiu S; Gao S; Huang X; Zhang J; Peng X; Qiani W; Zhang JY
Int J Immunopathol Pharmacol; 2009; 22(3):735-43. PubMed ID: 19822090
[TBL] [Abstract][Full Text] [Related]
19. Cancer-testis antigen GAGE-1 expression and serum immunoreactivity in hepatocellular carcinoma.
Chao NX; Li LZ; Luo GR; Zhong WG; Huang RS; Fan R; Zhao FL
Niger J Clin Pract; 2018 Oct; 21(10):1361-1367. PubMed ID: 30297572
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
Ying X; Zhao Y; Wang JL; Zhou X; Zhao J; He CC; Guo XJ; Jin GH; Wang LJ; Zhu Q; Han SX
Oncol Rep; 2014 Oct; 32(4):1550-6. PubMed ID: 25109745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
